CDNA CareDx, Inc Stock Quote

CDNA [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	-	EPS (ttm)	-0.94	Insider Own	1.40%	Shs Outstand	53.02M	Perf Week	-1.45%
Market Cap	1.34B	Forward P/E	410.48	EPS next Y	0.06	Insider Trans	-12.29%	Shs Float	52.15M	Perf Month	-16.47%
Income	-49.60M	PEG	-	EPS next Q	-0.05	Inst Own	-	Short Float	8.49%	Perf Quarter	-32.18%
Sales	308.40M	P/S	4.34	EPS this Y	-45.80%	Inst Trans	3.77%	Short Ratio	5.40	Perf Half Y	-41.40%
Book/sh	8.63	P/B	3.00	EPS next Y	115.00%	ROA	-8.90%	Target Price	60.29	Perf Year	-65.40%
Cash/sh	6.17	P/C	4.19	EPS next 5Y	20.00%	ROE	-10.60%	52W Range	21.25 - 96.88	Perf YTD	-43.14%
Dividend	-	P/FCF	-	EPS past 5Y	24.50%	ROI	-6.10%	52W High	-76.49%	Beta	0.89
Dividend %	-	Quick Ratio	5.90	Sales past 5Y	48.80%	Gross Margin	66.70%	52W Low	7.20%	ATR	2.52
Employees	633	Current Ratio	6.10	Sales Q/Q	17.80%	Oper. Margin	-15.50%	RSI (14)	37.80	Volatility	8.53% 9.41%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-	Profit Margin	-16.10%	Rel Volume	2.29	Prev Close	25.86
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 05 AMC	Payout	-	Avg Volume	818.89K	Price	22.78
Recom	1.60	SMA20	-17.52%	SMA50	-30.44%	SMA200	-52.60%	Volume	482,231	Change	-11.91%

Apr-25-22

Initiated

Stephens

Overweight

$50

Jul-20-21

Resumed

BTIG Research

Buy

$115

Jun-03-21

Initiated

Goldman

Buy

$95

Feb-26-21

Downgrade

H.C. Wainwright

Buy → Neutral

Oct-30-20

Reiterated

H.C. Wainwright

Buy

$47 → $55

Oct-08-20

Reiterated

H.C. Wainwright

Buy

$45 → $47

Oct-02-20

Reiterated

H.C. Wainwright

Buy

$40 → $45

Aug-05-20

Reiterated

H.C. Wainwright

Buy

$37 → $40

Jun-26-20

Initiated

BTIG Research

Buy

$40

Jun-19-20

Reiterated

H.C. Wainwright

Buy

$40 → $37

Oct-01-19

Resumed

Craig Hallum

Buy

$48

May-09-19

Upgrade

H.C. Wainwright

Neutral → Buy

$30 → $43

Feb-15-19

Initiated

Jefferies

Buy

$35

Oct-23-18

Resumed

Raymond James

Strong Buy

$30

Sep-18-18

Reiterated

H.C. Wainwright

Neutral

$17 → $22

Nov-27-17

Initiated

H.C. Wainwright

Buy

$12

Jun-14-16

Reiterated

Mizuho

Buy

$12 → $8

Sep-29-15

Downgrade

Raymond James

Outperform → Mkt Perform

Sep-25-15

Initiated

Craig Hallum

Buy

Mar-18-15

Reiterated

Mizuho

Buy

$15 → $12

May-18-22 07:00AM	CareDx Sponsored ISHLT Innovation Challenge Award Tackles Chronic Lung Allograft Dysfunction GlobeNewswire -7.99%
May-17-22 07:00AM	In CareDx-Initiated IP Litigation Against Natera, Natera Now Drops 1 of 2 Patents Originally Asserted Against CareDx GlobeNewswire
May-16-22 09:00AM	Cathie Woods 2022 Portfolio: 10 Small-Cap Stock Picks Insider Monkey -5.03%
May-11-22 07:00AM	CareDx Showcases Latest Innovation in Transplantation at European EFI 2022 Conference GlobeNewswire -6.22%
May-05-22 05:35PM	CareDx (CDNA) Reports Q1 Loss, Tops Revenue Estimates Zacks -7.07%
04:01PM	CareDx Reports First Quarter 2022 Results GlobeNewswire
07:00AM	CareDx Validates Clinical Performance of AlloMap Kidney to Comprehensively Assess Transplant Rejection GlobeNewswire
Apr-29-22 07:05AM	These Charts Explain Why I'm Holding This Healthcare Company Motley Fool
Apr-28-22 10:45AM	CareDx Congratulates Board Member Dr. Hannah Valantine on ISHLT Lifetime Achievement Award GlobeNewswire
07:00AM	CareDx Extends Artificial Intelligence Leadership to Heart Transplantation GlobeNewswire
Apr-27-22 04:01PM	CareDx to Report First Quarter 2022 Financial Results GlobeNewswire
09:15AM	International Society for Heart and Lung Transplantation Foundation Selects Reg Seeto as Corporate Chair GlobeNewswire
Apr-22-22 07:00AM	CareDx Demonstrates Potential of AlloHeme and AlloCell for Allogeneic Cell Transplant and Therapy Monitoring at Transplantation & Cellular Therapy Meetings GlobeNewswire
Apr-21-22 07:10AM	CareDx Supports UC Davis Health Pluralist Program Aimed at Reducing Health Disparities in Organ Transplantation GlobeNewswire -7.11%
Apr-20-22 07:00AM	CareDx Showcases Leadership with Over 25 Oral Presentations and Posters at the International Society for Heart and Lung Transplantation Meeting GlobeNewswire
Apr-14-22 07:41AM	CareDx Reports Over 200,000 Heart Transplant Patient Results Served GlobeNewswire -6.86%
Apr-11-22 07:00AM	CareDx, the Leading Sponsor of UNOS Transplant Management Forum, Demonstrates the Value of Digital Solutions to Improve Pre-Transplant Patient Referral and Waitlisting Workflow GlobeNewswire
Apr-06-22 07:00AM	CareDx to Host Symposium at CEoT Featuring the Latest Multimodality Innovations in Kidney and Lung Transplant Surveillance GlobeNewswire
Mar-30-22 07:00AM	CareDx Partners with the European Society for Organ Transplantation to Provide Clinical Evidence Supporting the Use of AlloSeq cfDNA with European Transplant Healthcare Professionals GlobeNewswire -6.01%
Mar-29-22 07:00AM	CareDx Partners with HeartBrothers Foundation to Help Patients Living with Heart Failure and Heart Transplant GlobeNewswire +5.69%
Mar-24-22 07:00AM	CareDxs AlloCare App Now Integrated with TxAccess to Help Pre-Transplant Patients Navigate the Waitlist Process GlobeNewswire
Mar-23-22 07:00AM	CareDx Announces XenoSure and XenoMap GlobeNewswire -5.43%
06:00AM	UPDATE -- CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; Natera Intentionally Deceived Transplant Community GlobeNewswire
Mar-16-22 04:01PM	Miromatrix to Participate in CareDxs Xenotransplantation Innovation Day GlobeNewswire +7.80%
07:00AM	CareDx Brings Together Leading Transplant Experts to Share Latest Advancements in the Field of Xenotransplantation GlobeNewswire
Mar-15-22 11:20AM	CareDx Wins $44.9 Million in Damages in False Advertising Trial Investing.com +10.57%
Mar-14-22 08:06PM	CareDx Wins $44.9M in Damages in False Advertising Trial Against Natera; Natera Intentionally Deceived Transplant Community GlobeNewswire -8.41%
Mar-03-22 07:00AM	CareDx Announces Cibiltech Initiates CIBIL Study Using iBox Artificial Intelligence to Monitor Kidney Transplant Patients GlobeNewswire -5.71%
Mar-02-22 07:00AM	CareDx Partners with the National Kidney Foundation to Advocate for Kidney Transplant Patients GlobeNewswire
Feb-24-22 05:50PM	CareDx (CDNA) Reports Q4 Loss, Tops Revenue Estimates Zacks +12.38%
04:01PM	CareDx Reports Fourth Quarter and Full Year 2021 Results GlobeNewswire
Feb-22-22 07:00AM	CareDx Leads the Way in Xenotransplant Organ Surveillance in Monitoring Worlds First Successful Living Xenotransplantation GlobeNewswire
Feb-17-22 04:01PM	CareDx to Report Fourth Quarter and Full Year 2021 Financial Results GlobeNewswire -8.25%
Feb-14-22 07:00AM	On National Donor Day, CareDx Applauds Patient Advocacy Efforts Aimed at Increasing Donations for the Thousands of Patients Waiting for a Transplant GlobeNewswire
Feb-10-22 07:00AM	Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022 GlobeNewswire
Feb-08-22 07:00AM	CareDx Taps into Its Patient Network to Deliver Insights on Transplant Needs GlobeNewswire
Feb-07-22 07:00AM	CareDx Joins Forces with MOTTEP, The National Minority Organ Tissue Transplant Education Program, to Host Heart Health Webinar for Transplant Patients GlobeNewswire +6.21%
Feb-03-22 07:00AM	CareDx To Participate In Upcoming Conferences GlobeNewswire
Feb-02-22 05:38PM	Moody Aldrich Partners Llc Buys Switch Inc, The Howard Hughes Corp, Eastern Bankshares Inc, ... GuruFocus.com
Jan-27-22 01:38PM	Zweig-DiMenna Associates LLC Buys Caterpillar Inc, Macy's Inc, Teck Resources, Sells PayPal ... GuruFocus.com
Jan-25-22 10:53AM	Is CareDx (CDNA) Still a Worthy Investment Choice? Insider Monkey
Jan-20-22 07:00AM	CareDx Joins Forces with MOTTEP to Increase Organ Donations for Minority Transplant Patients and Support High-Risk, Underserved Communities GlobeNewswire
Jan-19-22 05:38PM	Searle & Co. Buys The Chemours Co, Wells Fargo, HireRight Holdings Corp, Sells CareDx Inc, ... GuruFocus.com
Jan-14-22 09:38AM	Mesirow Financial Investment Management, Inc. ... GuruFocus.com
Jan-12-22 07:00AM	Landmark ADMIRAL Study Publication with CareDxs AlloSure Kidney is the First Long-Term Multicenter Prospective Clinical Validation for Routine Organ Transplant Surveillance GlobeNewswire -5.36%
Jan-11-22 07:00AM	CareDx Partners with Multiple Biotechnology Companies to Use AlloCell in CAR T-Cell Therapy Clinical Studies GlobeNewswire
Jan-10-22 07:00AM	CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2021 GlobeNewswire +18.48%
Jan-07-22 07:00AM	NIH Study Shows Using CareDxs AlloSure Lung for Transplant Surveillance is More Effective than Diagnostic Bronchoscopy at Identifying Rejection GlobeNewswire
Jan-06-22 07:00AM	CareDx Successfully Completes CLIA Validation of AlloMap Kidney in Preparation for Commercial Launch GlobeNewswire
Jan-05-22 07:00AM	CareDx Expands Its Medication Adherence Services with the Acquisition of The Transplant Pharmacy GlobeNewswire -11.01%
Jan-04-22 07:00AM	CareDx Partners with ISHLT in a Transplant Innovation Research Grant to Improve Outcomes for Heart and Lung Transplant Patients GlobeNewswire
Dec-31-21 07:45PM	Ongoing Investigation Notice: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm NewMediaWire
07:00PM	ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
06:34PM	CareDx Shareholder Notice NewMediaWire
Dec-30-21 05:51PM	CareDx Shareholder Alert NewMediaWire
Dec-29-21 05:51PM	CareDx Investor Alert NewMediaWire
Dec-27-21 06:01PM	CareDx Investor Alert NewMediaWire
Dec-26-21 08:27AM	CareDx Shareholder Alert NewMediaWire
Dec-24-21 06:34PM	CareDx Investor Alert NewMediaWire
Dec-22-21 06:14PM	CareDx Shareholder Notice NewMediaWire
Dec-21-21 06:12PM	CareDx Shareholder Alert NewMediaWire
Dec-20-21 06:02PM	CareDx Investor Alert NewMediaWire
Dec-19-21 04:36PM	ROSEN, A TOP RANKED LAW FIRM, Encourages CareDx, Inc. Investors with Losses to Inquire About Securities Class Action Investigation - CDNA PR Newswire
04:00PM	10 Artificial Intelligence Stocks in Cathie Woods Portfolio Insider Monkey
08:27AM	Action Alert: CareDx Shareholder NewMediaWire
Dec-18-21 02:38AM	Putnam Funds Trust Buys Definitive Healthcare Corp, F45 Training Holdings Inc, RBC Bearings ... GuruFocus.com
Dec-17-21 06:34PM	CareDx Investor Alert NewMediaWire +7.11%
Dec-16-21 06:49PM	Lost Money in CareDx, Inc.? Business Wire -5.13%
07:00AM	CareDx Enrolls First Patient in LungCare Registry Study to Measure Impact of Multimodality Assessment on Lung Transplant Patient Outcomes GlobeNewswire
Dec-13-21 07:00AM	CareDx Partners with the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Organization in Launching Prospective, Multi-Center Pediatric Kidney Transplant Study GlobeNewswire
Dec-12-21 09:00PM	CAREDX ALERT: Bragar Eagel & Squire, P.C. is Investigating CareDx, Inc. on Behalf of CareDx Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
Dec-10-21 12:30PM	Hedge Funds Are Getting More Bullish On CareDx, Inc. (CDNA) Insider Monkey
Dec-07-21 09:00PM	CAREDX ALERT: Bragar Eagel & Squire, P.C. is Investigating CareDx, Inc. on Behalf of CareDx Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
03:59PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firms Attorneys, Firm Investigating Possible Securities Law Violations GlobeNewswire
02:33PM	Cathie Woods ARK Portfolio: Top 15 Losers Insider Monkey
02:03PM	ROSEN, RESPECTED INVESTOR COUNSEL, Encourages CareDx, Inc. Investors to Inquire About Securities Class Action Investigation - CDNA PR Newswire
Dec-03-21 08:06PM	ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm Newsfile
06:34PM	CareDx Investor Alert Newsfile
Dec-02-21 09:00PM	CAREDX ALERT: Bragar Eagel & Squire, P.C. is Investigating CareDx, Inc. on Behalf of CareDx Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
06:38PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firms Attorneys, Firm Investigating Possible Securities Law Violations GlobeNewswire
06:33PM	CareDx Update Newsfile
10:00AM	ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
07:00AM	CareDx The Transplant Company Surpasses 80,000 Patient Milestone GlobeNewswire
Dec-01-21 06:32PM	Insider Buying Could Indicate a Bottom in These 2 Strong Buy Stocks TipRanks
06:32PM	CareDx Shareholder Notice Newsfile
09:11AM	Acushnet Holdings, CareDx, Lululemon and Chewy highlighted as Zacks Bull and Bear of the Day Zacks
07:09AM	Bear Of The Day:CareDX Zacks
Nov-30-21 06:23PM	CareDx Shareholder Alert Newsfile
10:05AM	INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm ACCESSWIRE
Nov-29-21 06:02PM	CareDx Investor Alert Newsfile
06:57AM	3 Unstoppable Growth Stocks You Can Buy for Less Than $100 Right Now Motley Fool
Nov-28-21 08:22AM	CareDx Shareholder Alert Newsfile
Nov-27-21 05:00AM	CAREDX ALERT: Bragar Eagel & Squire, P.C. is Investigating CareDx, Inc. on Behalf of CareDx Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
Nov-26-21 06:24PM	CareDx Investor Alert Newsfile
10:12AM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations Newsfile
Nov-25-21 06:18PM	CareDx Update Newsfile
Nov-24-21 07:33PM	SHAREHOLDER ALERT: WeissLaw LLP Investigates CareDx, Inc. PR Newswire +5.21%
06:12PM	CareDx Shareholder Notice Newsfile
Nov-23-21 08:07PM	INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against CareDx, Inc and Encourages Investors with Losses to Contact the Firm PR Newswire
04:42PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firms Attorneys, Firm Investigating Possible Securities Law Violations GlobeNewswire

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Colon Grace	Director	May 11	Sale	23.01	5,179	119,169	2,522	May 13 05:21 PM
Goldberg Michael	Director	Apr 11	Option Exercise	1.22	500	610	62,767	Apr 13 05:12 PM
Goldberg Michael	Director	Apr 11	Sale	36.01	500	18,006	62,267	Apr 13 05:12 PM
Maag Peter	Director	Apr 05	Option Exercise	21.74	9,950	216,277	321,689	Apr 06 05:03 PM
Maag Peter	Director	Apr 05	Sale	38.64	10,000	386,394	311,689	Apr 06 05:03 PM
Seeto Reginald	See Remarks	Mar 21	Sale	40.43	2,888	116,774	187,282	Mar 23 05:05 PM
Goldberg Michael	Director	Mar 09	Option Exercise	1.22	500	610	61,767	Mar 11 05:16 PM
Goldberg Michael	Director	Mar 09	Sale	33.41	500	16,704	61,267	Mar 11 05:16 PM
Colon Grace	Director	Mar 09	Sale	34.56	1,393	48,146	7,701	Mar 11 05:15 PM
Maag Peter	Director	Mar 07	Option Exercise	19.33	4,056	78,382	321,739	Mar 08 05:16 PM
Maag Peter	Director	Mar 07	Sale	32.81	10,000	328,063	311,739	Mar 08 05:16 PM
Seeto Reginald	See Remarks	Mar 01	Sale	38.62	3,153	121,754	190,170	Mar 01 08:49 PM
Bickerstaff George	Director	Feb 28	Sale	39.11	25,000	977,673	37,736	Mar 01 08:48 PM
Goldberg Michael	Director	Feb 09	Option Exercise	1.22	500	610	61,767	Feb 10 05:23 PM
Seeto Reginald	See Remarks	Feb 09	Sale	45.00	2,550	114,759	190,170	Feb 10 05:26 PM
Goldberg Michael	Director	Feb 09	Sale	42.96	500	21,480	61,267	Feb 10 05:23 PM
Maag Peter	Director	Feb 07	Sale	42.07	10,000	420,668	317,683	Feb 08 09:58 PM
Seeto Reginald	See Remarks	Feb 04	Sale	40.34	4,988	201,237	192,720	Feb 04 05:47 PM
Seeto Reginald	See Remarks	Feb 02	Sale	41.25	3,182	131,258	126,746	Feb 04 05:47 PM
Seeto Reginald	See Remarks	Feb 01	Sale	42.13	814	34,294	129,928	Feb 03 08:26 PM
Seeto Reginald	See Remarks	Jan 19	Sale	40.05	3,137	125,634	132,560	Jan 19 04:49 PM
Seeto Reginald	See Remarks	Jan 18	Sale	40.07	1,719	68,881	135,697	Jan 19 04:49 PM
Goldberg Michael	Director	Jan 10	Option Exercise	1.22	500	610	61,767	Jan 11 05:52 PM
Goldberg Michael	Director	Jan 10	Sale	42.97	500	21,485	61,267	Jan 11 05:52 PM
Maag Peter	Director	Jan 05	Option Exercise	24.30	10,000	242,986	351,756	Jan 06 06:07 PM
Maag Peter	Director	Jan 05	Sale	44.45	10,000	444,466	341,756	Jan 06 06:07 PM
Goldberg Michael	Director	Dec 09	Option Exercise	1.22	500	610	61,068	Dec 13 06:30 PM
Goldberg Michael	Director	Dec 09	Sale	45.41	500	22,705	60,568	Dec 13 06:30 PM
Maag Peter	Director	Dec 06	Option Exercise	18.90	10,000	188,951	351,756	Dec 07 04:29 PM
Maag Peter	Director	Dec 06	Sale	41.62	10,000	416,190	341,756	Dec 07 04:29 PM
Dhingra Ankur	Chief Financial Officer	Nov 24	Buy	42.34	5,000	211,694	5,000	Nov 29 04:19 PM
Goldberg Michael	Director	Nov 09	Option Exercise	1.22	500	610	61,068	Nov 10 04:47 PM
Goldberg Michael	Director	Nov 09	Sale	47.54	500	23,770	60,568	Nov 10 04:47 PM
Maag Peter	Director	Nov 05	Option Exercise	18.90	10,000	188,969	351,756	Nov 09 06:01 PM
TORRES ARTHUR A	Director	Nov 05	Buy	47.62	600	28,572	2,855	Nov 09 05:47 PM
Maag Peter	Director	Nov 05	Sale	49.40	10,000	494,000	341,756	Nov 09 06:01 PM
Goldberg Michael	Director	Oct 11	Option Exercise	1.22	500	610	61,068	Oct 12 05:19 PM
Goldberg Michael	Director	Oct 11	Sale	62.50	500	31,251	60,568	Oct 12 05:19 PM
Maag Peter	Executive Chair	Oct 05	Option Exercise	18.17	10,000	181,661	351,756	Oct 06 07:40 PM
Maag Peter	Executive Chair	Oct 05	Sale	64.67	10,000	646,735	341,756	Oct 06 07:40 PM
Maag Peter	Executive Chair	Sep 07	Option Exercise	10.65	3,448	36,718	351,756	Sep 07 08:36 PM
Maag Peter	Executive Chair	Sep 07	Sale	73.68	10,000	736,763	341,756	Sep 07 08:36 PM
Seeto Reginald	See Remarks	Aug 27	Sale	80.00	658	52,642	142,534	Aug 27 04:43 PM
Seeto Reginald	See Remarks	Aug 11	Option Exercise	27.72	10,821	299,958	143,192	Aug 17 06:59 PM
Maag Peter	Executive Chair	Aug 05	Option Exercise	11.36	4,958	56,333	354,256	Aug 09 04:56 PM
Maag Peter	Executive Chair	Aug 05	Sale	83.13	10,000	831,313	349,298	Aug 09 04:56 PM
Seeto Reginald	See Remarks	Jul 08	Sale	85.67	5,994	513,503	132,634	Jul 09 07:28 PM
Maag Peter	Executive Chair	Jul 06	Option Exercise	12.24	2,312	28,299	374,256	Jul 07 06:31 PM
Maag Peter	Executive Chair	Jul 06	Sale	90.70	10,000	907,002	364,256	Jul 07 06:31 PM
Seeto Reginald	See Remarks	Jun 28	Option Exercise	26.84	13,212	354,613	145,583	Aug 17 06:59 PM
Seeto Reginald	See Remarks	Jun 28	Sale	95.75	13,212	1,264,990	132,371	Aug 17 06:59 PM
Maag Peter	Executive Chair	Jun 25	Option Exercise	24.35	395	9,618	372,339	Jun 25 07:54 PM
Seeto Reginald	See Remarks	Jun 25	Option Exercise	26.53	9,210	244,359	141,581	Aug 17 06:59 PM
Seeto Reginald	See Remarks	Jun 25	Sale	95.15	9,210	876,318	132,371	Aug 17 06:59 PM
Maag Peter	Executive Chair	Jun 25	Sale	95.00	395	37,525	371,944	Jun 25 07:54 PM
Maag Peter	Executive Chair	Jun 24	Option Exercise	23.76	9,605	228,217	381,549	Jun 25 07:54 PM
Maag Peter	Executive Chair	Jun 24	Sale	95.30	9,605	915,398	371,944	Jun 25 07:54 PM
Maag Peter	Executive Chair	Jun 09	Option Exercise	24.35	2,522	61,411	374,466	Jun 11 05:52 PM
HAGSTROM WILLIAM A	Director	Jun 09	Option Exercise	4.95	5,000	24,750	23,575	Jun 11 05:52 PM
King Sasha	Chief Marketing Officer	Jun 09	Option Exercise	5.25	5,055	26,520	52,574	Jun 11 05:51 PM
Seeto Reginald	See Remarks	Jun 09	Option Exercise	26.56	16,718	444,066	159,352	Jun 11 05:51 PM
King Sasha	Chief Marketing Officer	Jun 09	Sale	90.01	12,435	1,119,263	40,139	Jun 11 05:51 PM
HAGSTROM WILLIAM A	Director	Jun 09	Sale	88.14	5,000	440,706	18,575	Jun 11 05:52 PM
Maag Peter	Executive Chair	Jun 09	Sale	90.00	2,522	226,982	371,944	Jun 11 05:52 PM
Seeto Reginald	See Remarks	Jun 09	Sale	90.01	16,718	1,504,819	142,634	Jun 11 05:51 PM
Maag Peter	Executive Chair	Jun 08	Option Exercise	24.35	978	23,814	372,922	Jun 09 08:27 PM
King Sasha	Chief Marketing Officer	Jun 08	Option Exercise	16.04	1,000	16,037	48,519	Jun 09 08:30 PM
Seeto Reginald	See Remarks	Jun 08	Option Exercise	27.72	500	13,860	143,134	Jun 09 08:32 PM
King Sasha	Chief Marketing Officer	Jun 08	Sale	90.02	1,000	90,024	47,519	Jun 09 08:30 PM
Maag Peter	Executive Chair	Jun 08	Sale	90.05	978	88,074	371,944	Jun 09 08:27 PM
Seeto Reginald	See Remarks	Jun 08	Sale	90.00	500	45,001	142,634	Jun 09 08:32 PM
King Sasha	Chief Marketing Officer	Jun 07	Option Exercise	20.13	8,071	162,438	55,590	Jun 08 06:37 PM
Seeto Reginald	See Remarks	Jun 07	Option Exercise	27.72	9,973	276,452	152,607	Jun 08 06:39 PM
Maag Peter	Executive Chair	Jun 07	Option Exercise	19.37	7,592	147,021	398,444	Jun 08 06:41 PM
Maag Peter	Executive Chair	Jun 07	Sale	86.25	26,500	2,285,752	371,944	Jun 08 06:41 PM
Seeto Reginald	See Remarks	Jun 07	Sale	90.01	9,973	897,644	142,634	Jun 08 06:39 PM
King Sasha	Chief Marketing Officer	Jun 07	Sale	90.01	8,071	726,461	47,519	Jun 08 06:37 PM
SNYDERMAN RALPH	Director	Jun 02	Sale	81.57	2,511	204,815	51,015	Jun 10 05:32 PM
SNYDERMAN RALPH	Director	Jun 01	Sale	77.30	2,512	194,173	53,526	Jun 10 05:32 PM
SNYDERMAN RALPH	Director	May 28	Sale	81.08	2,511	203,595	56,038	Jun 10 05:32 PM
SNYDERMAN RALPH	Director	May 27	Sale	81.01	1,966	159,266	58,549	Jun 10 05:32 PM
Maag Peter	Executive Chair	May 25	Option Exercise	27.17	10,000	271,700	419,444	May 27 05:04 PM
Maag Peter	Executive Chair	May 25	Sale	80.59	10,000	805,871	409,444	May 27 05:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience